Details of the Drug

General Information of Drug (ID: DMRMMAA)

Drug Name

TARA-002

Indication

Disease Entry	ICD 11	Status	REF
Lymphatic malformation	LA90.1	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05871970) A Phase 2a/b Single Arm Open Label Study to Evaluate the Safety and Efficacy of Intracystic Administration of TARA-002 in Participants Between 6 Months to Less Than 18 Years of Age for the Treatment of Macrocystic and Mixed Cystic Lymphatic Malformations. U.S.National Institutes of Health.